Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.45 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.43 |
| ▸ | TAS2R38 | P59533 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | CDK9 | P50750 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18520538 | 1.00 | CYP1A2 (0.46) | CYP1A2CYP2C19ABCC9KCNJ11ALDH1A1 | |
| SCHEMBL24726744 | 1.00 | CYP1A2 (0.46) | CYP1A2CYP2C19ABCC9KCNJ11ALDH1A1 | |
| SCHEMBL8854243 | 0.89 | ABCC9 (0.40) | CYP1A2CYP2C19ABCC9KCNJ11ALDH1A1 | |
| SCHEMBL13523189 | 0.82 | GAA (0.43) | ABCC9KCNJ11ALDH1A1KDM4EGAA | |
| SCHEMBL11236635 | 0.80 | TDP1 (0.44) | CYP1A2CYP2C19ABCC9KCNJ11ALDH1A1 | |
| SCHEMBL160934 | 0.80 | CYP3A4 (0.48) | CYP1A2CYP2C19ABCC9KCNJ11ALDH1A1 | |
| SCHEMBL1108190 | 0.80 | MAPT (0.47) | ALDH1A1KDM4EGAASMN1; SMN2TP53 | |
| SCHEMBL35172 | 0.79 | HSD17B10 (0.55) | ALDH1A1KDM4EGAATAS2R38HSD17B10 | |
| Benzene SCHEMBL27899223 | 0.79 | HSD17B10 (0.55) | ALDH1A1KDM4EGAATAS2R38HSD17B10 | |
| SCHEMBL20163213 | 0.79 | HSD17B10 (0.55) | ALDH1A1KDM4EGAATAS2R38HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113149917-B | Preparation method of triazine compound | 浙江工业大学 | 2023-01-10 | — | — | CN | claimed |
| CN-113149917-A | Preparation method of triazine compound | 浙江工业大学 | 2021-07-23 | — | — | CN | claimed |
| CN-1198489-A | Composition having no formol used for nonwoven cloth | ROHM & HAAS (US) | 1998-11-11 | — | — | CN | claimed |
| US-4347310-A | INCREASED PHOTOSENZITIVITY USING GUANIDINE DERIVTIVES AS SENSITIZERS; PHOTOSTABILITY; STORAGE STABILITY | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-08-31 | — | — | US | claimed |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-07-24 | — | — | US | disclosed |
| EP-3534867-B1 | MEDICAL COMPOSITION CONTAINING GUANIDINYL-CONTAINING POLYMER(S) AND CARRAGEENANE(S) | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-3534866-B1 | METHOD OF DENTAL RETRACTION WITH COMPOSITION WITH GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-05-28 | — | — | EP | disclosed |
| US-12295369-B2 | Articles containing a crosslinked guanidinyl-containing polymer and uses thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-05-13 | — | — | US | disclosed |
| US-20250145760-A1 | EPOXY RESIN COMPOSITIONS COMPRISING DICYANDIAMID CURING AGENT | 3M INNOVATIVE PROPERTIES COMPANY | 2025-05-08 | — | — | US | disclosed |
| US-20250082440-A1 | Composition for Isolating Tissue | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-03-13 | — | — | US | disclosed |
| CN-119072512-A | Epoxy resin composition comprising dicyandiamide curing agent | 3M创新有限公司 | 2024-12-03 | — | — | CN | disclosed |
| EP-4442727-A1 | EPOXY RESIN COMPOSITIONS COMPRISING A LEWIS ACID | 3M Innovative Properties Company (US) | 2024-10-09 | — | — | EP | disclosed |
| CN-1104520-C | Composition having no formol used for nonwoven cloth | ROHM & HAAS (US) | 2003-04-02 | — | — | CN | disclosed |
| CN-1198489-A | Composition having no formol used for nonwoven cloth | ROHM & HAAS (US) | 1998-11-11 | — | — | CN | disclosed |
| US-4347310-A | INCREASED PHOTOSENZITIVITY USING GUANIDINE DERIVTIVES AS SENSITIZERS; PHOTOSTABILITY; STORAGE STABILITY | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1982-08-31 | — | — | US | disclosed |
| US-4265905-A | FOR AUTOIMMUNE DISEASES | MERCK & CO., INC. (US) | 1981-05-05 | — | — | US | disclosed |
| US-4202903-A | Acyl cyanoguanidines for treating rheumatoid arthritis | MERCK & CO., INC. (US) | 1980-05-13 | — | — | US | disclosed |
| US-4024105-A | PLASTICS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
| US-3996232-A | ANTIULCER AGENTS | WILLIAM H. RORER, INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3969292-A | Stabilized molding compositions based on poly(oxymethylene) | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12295369-B2 | Articles containing a crosslinked guanidinyl-containing polymer and uses thereof | C5, YTHDC1, PRMT1 | CYP1A2 1588/4885CYP2C19 2191/4885ABCC9 4039/4885 |
| US-20250145760-A1 | EPOXY RESIN COMPOSITIONS COMPRISING DICYANDIAMID CURING AGENT | DDAH1, PHOSPHO1, QDPR | CYP1A2 4049/4885CYP2C19 3755/4885ABCC9 2717/4885 |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | GSDMD, PIGS, GANC | CYP1A2 4378/4885CYP2C19 2713/4885ABCC9 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.